Pharmaceuticals

Therapeutics MD

Therapeutics MD released FY2026 Q1 earnings on May 12 (EST), actual revenue USD 724K, actual EPS USD 0.0082

Therapeutics MD released FY2025 Q4 earnings on March 30 (EST), actual revenue USD 893 K, actual EPS USD -0.057

Therapeutics MD released FY2025 earnings on March 30 (EST), actual revenue USD 3.022 M (forecast USD 9.2 M), actual EPS USD -0.0527 (forecast USD 0.16)

Therapeutics MD released FY2025 Q3 earnings on November 12, 2025 (EST) with actual revenue of USD 784 K and EPS of USD 0.01

Therapeutics MD released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 2.129 M, actual EPS USD -0.0038

Therapeutics MD released FY2025 Semi-Annual Earnings on August 12 EST, with actual revenue of USD 1.345 M and EPS of USD -0.0109

Therapeutics MD released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 952K, actual EPS USD 0.0476

Therapeutics MD released FY2025 Q1 earnings on May 13, 2025 (EST) with actual revenue of USD 393K and EPS of USD -0.0614

Therapeutics MD released FY2024 annual earnings on March 27 (EST), actual revenue 1.761 M USD (forecast 9 M USD), actual EPS -0.1891 USD (forecast 0.15 USD)

Therapeutics MD released FY2024 Q4 earnings on March 27 (EST), actual revenue 667 K USD (forecast 2.3 M USD), actual EPS 0.0218 USD (forecast 0.04 USD)

Therapeutics MD released FY2024 9 Months Earnings on November 12, 2024 (EST), with actual revenue of 1,094,000 USD and EPS of -0.2118

Therapeutics MD released FY2024 Q3 earnings on November 12 (EST), actual revenue $547,000 (forecast $2.3M), actual EPS -0.0536 (forecast 0.04)

Freecast

Cuprina

U-BX Tech

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Defiance Pure Space Dly 2X Strat ETF

VS MEDIA

Everbright Digital

Park Ha Biological Tech

Friedman Industries

Defiance Daily Target 2X Short ASTS ETF

CUPR

TXMD

During Friday's intraday session, several healthcare stocks experienced significant volatility. Cuprina Holdings surged 92.2% to $4.63, while Akanda rose 24.75%. Other gainers included Cartesian Therapeutics, Shattuck Labs, Aditxt, and TherapeuticsMD. Conversely, Gelteq plummeted 37.2% to $0.96, with BiomX, Propanc Biopharma, Aspire Biopharma, WORK Medical Tech, and AIM ImmunoTech also posting notable declines.

benzinga_article

AIM ImmunoTech

Cartesian Therapeutics

Akanda

WORK Medical Tech

Aditxt

BiomX

Gelteq

Propanc Biopharma

Shattuck Labs

Aspire Biopharma

PROPANC BIOPHARMA INC

ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM)

AIM IMMUNOTECH INC

AIM ImmunoTech Inc.

12 Health Care Stocks Moving In Friday's Intraday Session

TherapeuticsMD Inc. (TXMD) shares fell 2.15% to $1.82 on Thursday, underperforming the broader market and competitors like AbbVie despite a strong trading session for major indices. This marks the stock's second consecutive day of losses, with prices now 38.31% below its 52-week high. Trading volume exceeded its 50-day average.

MarketWatch Automated

NASDAQ Composite Index

Dow Jones Industrial Average

Abbvie

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors

ABBV

AbbVie Inc. (ABBV) shares fell 1.83% to $223.07 on Monday, snapping a four-day winning streak and underperforming competitors like Johnson & Johnson, Pfizer, and Amgen. The decline occurred during a mixed market session where the S&P 500 rose slightly while the Dow Jones dipped. AbbVie closed 8.88% below its 52-week high of $244.81 set in October. Trading volume was lower than the 50-day average.

S&P 500

Johnson & Johnson

Pfizer

Amgen

Factset Research

AbbVie Inc. Stock Underperforms Monday When Compared To Competitors

TherapeuticsMD Inc. (TXMD) shares rose 1.52% to $2.00 on Thursday, ending a three-day losing streak. However, the stock underperformed compared to competitors like AbbVie, which gained 3.60%. Trading volume was significantly below the 50-day average. The stock remains 32.20% short of its 52-week high of $2.95 set in January.

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

TherapeuticsMD Inc. (TXMD) shares fell 3.43% to $1.97 on Wednesday, underperforming competitors like AbbVie amid a broader market decline. This marks the stock's third consecutive day of losses, with prices now 33.22% below its 52-week high. Trading volume significantly exceeded the 50-day average.

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

NTAP

NetApp Inc. (NTAP) shares fell 2.26% to $175.64 on Tuesday, underperforming the broader market and key competitors like Cloudflare, Arista Networks, and Western Digital. This decline ended a two-day winning streak, with the stock trading 8.91% below its 52-week high of $192.83. Trading volume reached 4.7 million, surpassing the 50-day average.

NetApp

CloudFlare

Arista Networks

Western Digital

Western Digital - WI

NetApp Inc. Stock Underperforms Tuesday When Compared To Competitors

LABD

ARKG

TherapeuticsMD Inc. (TXMD) shares rose 1.44% to $2.11 on a positive trading day, marking the fifth consecutive day of gains. The stock remains 28.47% below its 52-week high of $2.95. In comparison, AbbVie Inc. (ABBV) increased by 1.04% to $214.50. Trading volume was below the 50-day average.

Therapeutics MD(TXMD.US)